Together, these findings suggest that an increase in the expression of muscle specific E3-ligases (i.e. atrogin-1 and MuRF1) play a crucial role in statin-induced muscle fiber atrophy/damage and may help to explain muscle pain and weakness associated with statin-myopathy. The gene discussed is FBXO32; the disease is myopathy.